Otsuka Pakistan Limited (PSX:OTSU)
189.53
-3.50 (-1.81%)
At close: May 13, 2025
Otsuka Pakistan Revenue
Otsuka Pakistan had revenue of 884.76M PKR in the quarter ending March 31, 2025, with 56.21% growth. This brings the company's revenue in the last twelve months to 3.69B, up 30.58% year-over-year. In the fiscal year ending June 30, 2024, Otsuka Pakistan had annual revenue of 3.16B with 4.24% growth.
Revenue (ttm)
3.69B
Revenue Growth
+30.58%
P/S Ratio
0.62
Revenue / Employee
10.70M
Employees
345
Market Cap
2.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
Jun 30, 2021 | 2.55B | 319.29M | 14.34% |
Jun 30, 2020 | 2.23B | 342.24M | 18.16% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.15B |
Abbott Laboratories (Pakistan) | 69.49B |
AGP Limited | 26.27B |
Highnoon Laboratories | 25.51B |
The Searle Company | 28.80B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 18.16B |